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Galaxy Integrated Omics: Web-based
Standards-Compliant Workflows for
Proteomics Informed by Transcriptomics*□S
Jun Fan‡, Shyamasree Saha‡, Gary Barker¶, Kate J. Heesom, Fawaz Ghali**,
Andrew R. Jones**, David A. Matthews§, and Conrad Bessant‡ ‡‡
With the recent advent of RNA-seq technology the pro-
teomics community has begun to generate sample-spe-
cific protein databases for peptide and protein identifica-
tion, an approach we call proteomics informed by
transcriptomics (PIT). This approach has gained a lot of
interest, particularly among researchers who work with
nonmodel organisms or with particularly dynamic pro-
teomes such as those observed in developmental biology
and host-pathogen studies. PIT has been shown to im-
prove coverage of known proteins, and to reveal potential
novel gene products. However, many groups are impeded
in their use of PIT by the complexity of the required data
analysis. Necessarily, this analysis requires complex inte-
gration of a number of different software tools from at
least two different communities, and because PIT has a
range of biological applications a single software pipeline
is not suitable for all use cases. To overcome these prob-
lems, we have created GIO, a software system that uses
the well-established Galaxy platform to make PIT analysis
available to the typical bench scientist via a simple web
interface. Within GIO we provide workflows for four com-
mon use cases: a standard search against a reference
proteome; PIT protein identification without a reference
genome; PIT protein identification using a genome guide;
and PIT genome annotation. These workflows comprise
individual tools that can be reconfigured and rearranged
within the web interface to create new workflows to sup-
port additional use cases. Molecular & Cellular Pro-
teomics 14: 10.1074/mcp.O115.048777, 3087–3093, 2015.
Searching MS/MS spectra against a list of proteins that
could be present in the sample remains the pre-eminent
method for identifying proteins in liquid chromatography tan-
dem mass spectrometry (LC-MS/MS)1 shotgun proteomics.
The relevance and quality of this protein database, as it is
known, has been shown to have a significant impact on the
outcome of a proteomics study (1), but even for well-studied
model organisms the true set of proteins that might be ex-
pressed is debatable. For example, large scale human pro-
teome mapping projects have recently suggested that
commonly used human protein databases may include super-
fluous proteins while simultaneously omitting proteins for
which there is evidence of expression (2, 3). For lesser studied
organisms the situation is worse still, as available protein
databases rely even more on computational prediction, and in
some species even this is not possible as a reference genome
has not yet been assembled. This is a significant problem in
fields such as virology, where the disease vectors (e.g. mos-
quitoes, lice, ticks, birds, and bats) have poorly annotated
genomes or no genome data at all. Similar challenges can be
found in metaproteomics (4), where individual samples con-
tain proteins from multiple organisms, some of which may be
unidentified or not previously sequenced.
Recently, we sought to mitigate these problems by devel-
oping a methodology called proteomics informed by tran-
scriptomics (PIT) (5) in which sample-specific protein data-
bases are generated from transcripts that have been identified
in the same sample using RNA-seq (6). These transcripts can
be assembled from short reads either by mapping to a ge-
nome or entirely de novo (e.g. if no suitable genome exists).
Although we showed that PIT could provide valuable new
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insights into the systems being studied, the complexity of the
software pipeline needed to integrate the RNA-seq and pro-
teomic MS/MS data made it difficult to configure the method
for different applications and to adapt it to make use of new
transcriptomic and proteomic tools. In this paper we intro-
duce our solution to these challenges—a publicly available
standards-compatible system called GIO (Galaxy Integrated
Omics) that uses the popular Galaxy platform (7) to make
flexible PIT workflows available via an easy to use web inter-
face. We explain the workflows, the GIO implementation of
these workflows and validate the efficacy of this software
using a matched RNA-seq and LC-MS/MS dataset.
EXPERIMENTAL PROCEDURES
Software Implementation—
Use of the Galaxy Platform—Galaxy (7) is a highly customizable
server-based bioinformatics platform that has already amassed a
large following among the genomics community as a framework
within which complex analysis of large data sets can be easily con-
ducted in a repeatable way by non-bioinformaticians. It provides a
powerful web interface through which data can be uploaded, tools
executed, and workflows built, inspected, executed, and shared.
Because all the necessary tools and workflows reside on a centrally
managed server the need for users to download, install, and configure
software is avoided. This makes Galaxy an obvious platform for PIT
because PIT requires integration of a wide range of individual tools
from different domains. The simple concept behind Galaxy is that any
command line tool can be added to it by writing a wrapper that lists
the tool’s parameters, specifies its inputs and outputs, and defines
the command line syntax used to run the tool. Galaxy uses this
wrapper to automatically create a user interface for each tool, sub-
stituting the tool’s command line interface with a simple web-based
form. Because they define each tool’s input and output formats,
wrappers also allow tools to be linked together into workflows. Wrap-
pers allow a tool to be incorporated into Galaxy without changing the
tool’s program code, regardless of the programming language in
which the tool was written. Although it is possible to make tools and
workflows available for administrators of Galaxy servers to download
and install via a repository called Galaxy Tool Shed, configuring all the
necessary components can be complicated so we chose instead to
provide our workflows via a dedicated customized version of Galaxy
containing all relevant tools and workflows. A demonstration of this
customized Galaxy version, which we call Galaxy Integrated Omics
(GIO), is freely accessible at gio.sbcs.qmul.ac.uk. We also maintain a
repository of the core GIO components, together with an automated
installation program, on GitHub (https://github.com/wizardfan/gio-
repository) so that groups who wish to add GIO functionality to their
own Galaxy server can do so.
Choice of Tools—There is a large and growing range of existing
command line proteomics tools available, offering a range of func-
tionality under various licensing arrangements (e.g. protein quantita-
tion tools have recently been reviewed (8)). For GIO we have selected
a subset of tools that covers the steps needed to construct PIT
workflows. These tools were chosen based on their perception within
the community and their ability to support data standards (see next
section). The key transcriptomic tools were already available in Gal-
axy Tool Shed, as were some of the proteomics tools (wrapped by the
GalaxyP project (9)). Given the difficulties of definitively benchmarking
the efficacy of individual tools it is impossible to be certain that our
selection is optimal, but the modular nature of Galaxy makes it
straightforward to add new tools, to replace individual workflow steps
in the future as better tools become available. Because the PIT
workflows contain novel functionality it was necessary to implement a
number of new tools, which are distinguished in GIO by names
prefixed with “PIT:.” These tools include a bespoke ORF finder called
PIT:ORFall, and PIT:Integrate for bringing transcriptomic and pro-
teomic data together using our previously described method (5).
Some of the PIT tools are themselves mini-workflows that combine
workflow steps that are commonly used together. For example, PIT:
PSM PostProcessing sequentially runs three individual tools from
mzIdentML-lib (10) to determine PSM level FDR scores, remove pep-
tides below a user-defined threshold, and map peptides to proteins.
Such meta-tools simplify the creation of workflows, improving their
readability and reducing the chance of errors.
Data Standards—One of the prerequisites for building workflows is
that individual tools must be compatible such that the output of one tool
can be used as the input to another. To ensure this, GIO supports PSI
data standards (10). In particular, we provide a number of tools from
mzIdentML-lib (11) to support the manipulation of the mzIdentML (12)
files. For spectral data, GIO supports the PSI standard mzML (13)
format. Data in other formats can be converted to mzML using Pro-
teoWizard’s MSConvert (14) within GIO. Because the libraries needed
to convert proprietary raw binary data formats are only available for
Microsoft Windows, MSConvert has been configured to run within a
Windows virtual machine on the GIO server, which is accessed by
GIO using Pulsar (15).
Data Processing Workflows—We have developed three primary
workflows for analyzing data from PIT experiments, and a standard
identification workflow for comparison purposes. Each of these work-
flows is available to view, edit, and execute on the GIO server (gio.
sbcs.qmul.ac.uk) where detailed tutorials are also provided. Applying
a workflow to a given data set is simply a case of uploading and
selecting which data files to use, selecting the workflow, and clicking
the execute button to run the workflow. All workflow parameters (e.g.
false discovery rate, threshold) can be set by the user, and workflows
can be substantially modified or created from scratch using the
available tools (e.g. multiple different tools are offered for peptide
spectrum matching via a tool called “Peptide spectrum matching”
that wraps SearchGUI (16)).
Standard Identification Workflow—Included primarily for testing
and comparison purposes, this is a standard protein identification
workflow to which the inputs are a spectra file and a list of protein
sequences to search against. By default, input formats for these files
are mzML and FASTA respectively, but any common formats (includ-
ing proprietary .raw) can be accommodated by using conversion
tools within GIO. The first step of the workflow is peptide spectrum
matching, performed by MS-GF (17). This is followed by a post
processing step that combines three tools from mzIdentML-lib (11) to
calculate the false discovery rate (FDR) for each peptide, removes
peptides below a specified threshold, and infers the identity of pro-
teins from the surviving peptides. The output of these steps is a single
mzIdentML file, from which the protein identifications are extracted
and converted into a tabular (tab separated values - TSV) file for
convenient viewing or downloading via the Galaxy interface. This
workflow is shown schematically in supplemental Fig. S1 in the sup-
plementary materials. In the common scenario where a sample has
been fractionated prior to MS, the ProteoWizard MSConvert tool (14)
within GIO can be used to merge all spectra data files into a single file
for input to the workflow.
PIT Workflow without Reference Genome—This is a development
of the standard identification workflow in which one of the inputs is a
list of de novo assembled transcripts instead of a protein list. To
reduce load on the public GIO server, we request that the transcript
list is assembled from acquired RNA-seq data outside of GIO using a
stand-alone tool such as Trinity (18) and then imported into GIO, but
on a locally installed GIO installation the transcript assembly step can
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be fully integrated into the workflow. The first step of the workflow
(shown in Fig. 1) produces a protein database comprising the longest
open reading frames (ORFs) found within all six reading frames of
each transcript. This database is then used in the peptide spectrum
matching step, which is followed by the same post processing as in
the previous workflow. Because the ORFs identified from this process
are unannotated sequences, further post processing is needed to
infer what they may be. This takes place in the final part of the
workflow, where all identified ORFs are BLASTed to find homologous
proteins in selected species. The final result of the workflow is there-
fore a tabular file containing a list of ORFs for which peptide evidence
has been found, together with an indication of the closest homolo-
gous protein in the selected species. This allows for the analysis of a
sample from a species for which a reference genome is not available,
by postidentification comparison with proteins in a closely related
species. It also facilitates metaproteomics where proteins from two or
more species (some of which may be unidentified) are present in the
sample.
PIT Workflow for Genome Annotation—If a genome exists for the
species under study, an alternative workflow can be used that in-
cludes additional steps to annotate the genome. In this workflow, in
parallel with the peptide and protein identification, de novo assem-
bled transcripts from the input file are mapped to the genome using
GMAP (19). At the end of the workflow the in-house PIT:Integrate tool
is used to integrate the identified transcriptomic and proteomic fea-
tures into a single GFF3 genome annotation file so that these features
can be viewed in their genomic context using a genome browser. The
same information is provided in tabular and SAM formats and, as in
the previous workflow, identified sequences are provided in FASTA
format so a homology search can be added at the end of this work-
flow to provide information as to what the identified proteins may be.
This workflow is shown schematically in supplemental Fig. S2 in the
supplementary materials.
PIT with Reference Genome—If the species under study has a well
annotated reference genome then instead of de novo transcript as-
sembly, transcript sequences can be determined by mapping the
acquired RNA-seq data to the reference genome using TopHat (20)
and assembling using Cufflinks (21). This functionality is provided by
a dedicated GIO workflow. In this workflow, instead of assembled
transcripts, inputs are RNA-seq FASTQ files containing quality con-
trolled forward and reverse reads. The first step in the workflow uses
TopHat to map short reads to the genome of the species under study.
This produces a BAM mapping file which is passed to the next step
in which Cufflinks assembles the reads into transcripts. These tran-
scripts are then used, as in the other workflows, to generate ORFs
against which the acquired MS spectra are searched. Downstream
processing also follows the same process as described previously for
the other workflows. This workflow is shown schematically in supple-
mental Fig. S3 in the supplementary materials.
Workflow Evaluation—Workflows were evaluated by applying them
to previously published (5) matched sets of RNA-seq and proteomic
MS/MS data acquired from HeLa cells infected with adenovirus. This
data represents a good case study because the samples contain
proteins from at least two species, and the data has already been
extensively analyzed using established tools so there is an opportu-
nity to compare results. Furthermore, the human proteome is argu-
ably the best annotated of any species, so it is possible to make a
FIG. 1. Annotated PIT workflow without reference genome. The inputs to the workflow are a file containing raw spectral data and a list
of transcripts assembled from RNA-seq data (assembled in a separate workflow using Trinity). In the first step of analysis, the longest open
reading frames (ORFs) in all six frames for each transcript are determined using the in-house ORFall tool. MS-GF then finds peptide spectrum
matches, which are post processed and grouped to proteins using tools from mzIdentML-lib. This results in a list of confidently identified ORFs
in mzIdentML format, which is then BLASTed against protein databases to add context to the results.
Galaxy Integrated Omics (GIO)
Molecular & Cellular Proteomics 14.11 3089
direct comparison of the results obtained with and without the use of
a reference proteome.
Detailed information about the laboratory protocols can be found in
the original publication (5), but in summary this was a triple SILAC
experiment in which different labels represented different time points
post infection. Cells were labeled with either (1) 15N- and 13C-labeled
arginine and lysine (heavy HeLa), (2) 13C-labeled arginine and lysine
(medium HeLa), or (3) were not labeled at all (light HeLa). The medium
and light HeLa cells were infected with adenovirus, and the heavy
HeLa cells were mock infected. Light cells were harvested at 8 h
postinfection, and medium and heavy cells harvested after 24 h. The
three samples were mixed together in a 1:1:1 ratio, digested with
trypsin, and subjected to CID LC-MS/MS shotgun proteomics on a
Thermo Orbitrap Velos mass spectrometer. Cytoplasmic mRNA was
harvested from the individual samples and RNA-seq conducted using
an Illumina GAIIx, resulting in the acquisition of 82 M paired-end
reads, with an average length of 56 bps.
Because the purpose of this study is protein identification, peptide




15N4-Arg for heavy labeled samples and
13C6-
Lys and 13C6-Arg for medium) as variable modifications, essentially
treating the data as a pooled sample. Oxidation of methionine was
also included as a variable modification, and carbamidomethylation of
cysteine as a fixed modification. Peptide spectrum matching was
performed for fully tryptic peptides, with any reasonable number of
missed cleavages (according to the MSGF algorithm), and mass
tolerances of 10 ppm for precursor ions and 0.8 Da for product ions.
A peptide level FDR threshold of 1% was applied throughout, and
only proteins with at least two identified peptides were retained. All
data used in this article is available as a Data Library within GIO.
RESULTS
Standard Identification Workflow—Searching the acquired
MS/MS data against a FASTA file concatenated from the
complete Uniprot proteomes of human (including isoforms)
and adenovirus type 5, 26,401 peptides were found by MS-
GF, which mapped to 3,015 proteins (2997 human and 18
human adenovirus). These figures (provided in Table I), and
the list of identified proteins that they represent, are compa-
rable with those obtained from the original analysis (5) of the
data using the Andromeda (22) search engine via MaxQuant.
The results of this standard workflow are used below as a
benchmark against which to evaluate the other workflows.
PIT Workflow without Reference Genome—Searching the
acquired MS/MS data against ORFs derived from Trinity de
novo assembly of RNA-seq transcripts identified 25,907 pep-
tides, which mapped to 2926 ORFs. Using the homology
search tool included in this workflow, 2889 of these ORFs
were identified as human proteins, and 18 identified as ade-
novirus proteins. Nineteen of the ORFs had no significant
homology to either human or adenovirus proteins.
Comparing the PIT results against those obtained using the
standard workflow, there is an overlap of 88% at the peptide
level (taking into account only exact peptide sequence
matches). A visual representation of these results is shown in
Fig. 2. Again, these results are comparable with those ob-
tained when PIT analysis was carried out previously on this
data using other tools. Table II shows more detailed informa-
tion about the number of peptides searched against in each
case, and the peptide identifications that were unique to each
search. This shows that the majority of peptides that were
only found in one search were because of the absence of the
peptide from the database used for the other search. The
remaining nonoverlapping peptide identifications were be-
cause of other differences in the protein database, including
the presence of sample-specific peptides in the PIT database
that get matched to spectra that would otherwise be matched
to peptides from Uniprot, and vice versa. It should also be
noted that the peptide identifications were counted after pro-
tein grouping, which also affects which peptide identifications
are retained.
Overlap at the protein level is more difficult to define, partly
because proteins are longer so the chance of an exact match
between a sample-specific ORF and a Uniprot protein are
lower than they would be at the peptide level, but also be-
cause peptides are assigned to protein ambiguity groups
(PAGs) rather than distinct proteins. A PAG contains one or
more proteins that are supported by a shared set of peptide
evidence, with the protein with the most evidence being des-
ignated as an anchor protein that represents the PAG. Often
several members of a PAG have equal peptide evidence, e.g.
they may be isoforms, so the anchor is selected using some
other criteria (e.g. in alphabetical order of their ID in the case
of mzIdentML-lib’s ProteoGrouper). Thus, when comparing
lists of protein identifications from searches against different
TABLE I









Transcripts n/a 103,431 n/a 37,024
Average transcript length n/a 670.03 n/a 1,007.21
Total components/genes n/a 92,661 n/a 33,747
Transcript N50 n/a 1,040 n/a 1,764
Proteins/ORFs 88,701 78,493 88,665 54,184
Identified peptides 26,401 25,907 25,970 21,601
Identified PAGs 3,015 2,926 2,986 2,713
Peptide level overlap 88% 77%
PAG level overlap 87% 75%
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databases there are several reasons why anchor proteins may
not match, even if the identified proteins are essentially the
same. For the purposes of this comparison, a BLAST e-value
below 1  1030 (widely regarded as indicating strong ho-
mology between sequences) was taken to indicate a match
between identified sequences. Using this threshold, a total of
2768 matches were found between PAGs from the standard
protein identification workflow and PAGs from the PIT work-
flow (1955 anchor–anchor matches plus a further 813
matches between anchors and PAG submembers).
No match could be found between 247 of the PAGs from
the standard workflow and the list of PAGs from the PIT
workflow, i.e. 247 proteins were unique to the Uniprot search.
Further analysis of these proteins was performed outside of
GIO to understand why they were missed by the PIT search.
Fourteen of the proteins were found to be isoforms or sub-
members of the overlapping PAGs. No transcript evidence
could be found for the genes coding for 85 of the proteins
(2.8% of the total identified by the standard workflow)—
clearly PIT alone is unable to detect such proteins because
the protein database is created purely from transcripts. Most
of these proteins (71 out of 85), were also missing from the
genome guided PIT workflow, suggesting either that the
genes were not being expressed in the sample (possible
because proteins can persist in a cell longer than the mRNA
that was used to create them) or the RNA-seq depth was too
shallow to detect them. The remaining 14 missing proteins
can be attributed to Trinity’s failure to assemble a small num-
ber of transcripts. Transcript evidence could be found for the
remaining 148 proteins, but the ORF finding tool had either
failed to produce ORFs from these transcripts or had pro-
duced ORFs that were not sufficient matches to proteins—
this suggests an area for improvement in this aspect of the PIT
methodology.
A total of 158 proteins were only found in the PIT search. On
further inspection, 139 of these were found to match to the
Uniprot proteome but were not found by the standard search,
mostly because each protein only had single peptide evi-
dence in that search, whereas two or more peptides were
found by PIT. This often occurred because of a longer ORF
sequence compared with the Uniprot protein, where the extra
peptide matched to the extended region, suggesting potential
deficiencies in the UniProt reference proteome that was used.
The remaining 19 identified ORFs did not have significant
homology to any known protein so have potential for future
investigation as novel translated genomic elements—these
ORFs, and the evidence for them, can be found in the sup-
plementary data.
PIT Workflow for Genome Annotation—The genome anno-
tating workflow was successfully applied to annotate the hu-
man genome with transcripts and peptides identified from the
acquired RNA-seq and proteomic MS data. An example sec-
tion of the GFF3 file visualized in the Genoverse (23) genome
browser is shown in supplemental Fig. S4. Obviously the
GFF3 file does not provide a complete annotation of the
human genome, as only genes and proteins expressed in
FIG. 2. Comparison of peptides and
protein groups identified by a stand-
ard protein identification workflow in
which mass spectra were searched
against Uniprot, and a PIT workflow
without reference genome, for HeLa
cells infected with adenovirus.
TABLE II






Unique identifications due to absence
of peptide in other database
Standard (human and adenovirus) 11,636,910 1,883 1,878 (99.7%)
PIT–de novo assembly 7,843,921 1,389 813 (58.5%)
Standard (human only) 11,627,809 5,215 5,187 (99.4%)
PIT–genome guided assembly 7,095,081 846 552 (65.2%)
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the individual analyzed sample are shown but it does allow for
the rapid visualization of peptide evidence in a genomic con-
text and the localization of putative novel translated genomic
elements.
PIT Workflow with Reference Genome—Searching the ac-
quired MS/MS data against ORFs derived from transcripts
assembled by Cufflinks and TopHat using reference genome
hg38, 21,601 peptides were found, which mapped to 2713
PAGs, whereas the standard workflow identified 2986 PAGs
when only human proteins were used. Using the homology
search tool included in this workflow, 2676 of these ORFs
were identified as human proteins. Because this workflow
used mapping to a human reference, adenovirus proteins
were not considered.
Comparing the PIT results against those obtained using
the standard workflow, there is an overlap of 77% at the
peptide level. A visual representation of these results is
shown in Fig. 3.
Using the same PAG comparison method as in the previous
section, a total of 2435 matches were found between PAGs
from the standard protein identification workflow and PAGs
from the PIT workflow (1630 anchor–anchor matches plus a
further 805 matches between anchors and PAG submem-
bers). The reduced overlap at both peptide and PAG level,
when compared with the previous workflows, is mostly likely
because Cufflinks produced fewer transcripts than Trinity (see
Table I), resulting in a significantly smaller number of ORFs in
the search database.
No match could be found between 551 of the PAGs from
the standard workflow and the list of PAGs from the PIT
workflow. However, isoforms of two of these proteins overlap
with the PIT search. No transcript evidence could be found for
246 of these proteins. A total of 278 PAGs were only found in
the PIT search. Of these, 241 ORFs had homology to human
Uniprot proteins but were not identified by the standard
search, mostly because these proteins had single peptide
evidence in the standard search.
DISCUSSION
Through the creation of GIO, we have demonstrated that
Galaxy is an extremely effective platform for putting powerful
integrative data analysis workflows into the hands of re-
searchers. The PIT results obtained using GIO are very similar
to those obtained previously from the same data using a
bespoke hard-coded pipeline composed of different tools.
The principal innovation is that the data analysis can now be
reliably carried out by a typical bench biologist via a web
interface without installing a single piece of software, whereas
the original analysis required many months of programming
and command line expertise. Although we have provided four
reference workflows for PIT analysis, GIO permits huge flex-
ibility in terms of generation of bespoke workflows for differ-
ent applications. For example, users can experiment with
different parameters, different tools for certain steps (e.g.
peptide spectrum matching, post processing), or generate
their own hybrid protein databases to search against using file
manipulation tools that are already built in to Galaxy. Ad-
vanced users who install Galaxy on their own server are able
to customize workflows even further, adding their application-
specific downstream analysis tools for example.
In future, we plan to add further tools and workflows to GIO,
to bring other complex proteomics data processing tasks
within reach of the typical bench biologist. Priorities include
tools for interpreting the results of PIT experiments, e.g. to
permit fine grained comparison of mzIdentML files from dif-
ferent searches and to classify potentially novel translated
genomic elements.
* This work was supported by BBSRC grants BB/K016075/1, BB/
K016075/1, BB/I001131/1, Wellcome Trust grant 083604 and Queen
Mary University of London.
□S This article contains supplemental Figs. S1 to S4.
‡‡ To whom correspondence should be addressed: School of Bi-
ological and Chemical Sciences, Queen Mary University of London,
Mil End Road, London E1 4NS, United Kingdom. Tel.: 44-20-7882
6510; E-mail: c.bessant@qmul.ac.uk.
FIG. 3. Comparison of peptides and
protein groups identified by a stand-
ard protein identification workflow in
which mass spectra were searched
against Uniprot, and a PIT workflow
using a human reference genome, for
HeLa cells infected with adenovirus.
Because a human reference genome
was used, only human protein identifica-
tions are included in these results.
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